Lee's Pharmaceutical Holdings Limited
LPCUF
Get informed when a big investor buys or sells
+ FollowMarket Cap$112.06M
Close$
$-0.02
111.9% downside
Current Fair Value
111.9% downsideOvervalued by 111.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $112.06 Million |
|---|---|
| Enterprise Value | $-2,464,012.00 |
| Dividend Yield | $0.01 (5.04%) |
| Earnings per Share | $0.16 |
| Beta | 0.6 |
| Outstanding Shares | 588,835,000 |
Return
| Return on Equity | 8.45% |
|---|---|
| Return on Assets | 5.16% |
| Return on Invested Capital | -0.46% |
Valuation & Multiples
| P/E Ratio | 4.07 |
|---|---|
| PEG | 2.23 |
| Price to Sales | 0.06 |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | 0.24 |
| Enterprise Value to EBIT | -51.76 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lee's Pharmaceutical Holdings Limited
1,094 employees
CEO: Wanee Leelalertsuphakun Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease are...